These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9690172)

  • 1. Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases.
    Marelius J; Graffner-Nordberg M; Hansson T; Hallberg A; Aqvist J
    J Comput Aided Mol Des; 1998 Mar; 12(2):119-31. PubMed ID: 9690172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding mode analysis of 2,4-diamino-5-methyl-5-deaza-6-substituted pteridines with Mycobacterium tuberculosis and human dihydrofolate reductases.
    da Cunha EF; Ramalho TC; Reynolds RC
    J Biomol Struct Dyn; 2008 Feb; 25(4):377-85. PubMed ID: 18092832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
    da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
    J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational predictions of binding affinities to dihydrofolate reductase: synthesis and biological evaluation of methotrexate analogues.
    Graffner-Nordberg M; Marelius J; Ohlsson S; Persson A; Swedberg G; Andersson P; Andersson SE; Aqvist J; Hallberg A
    J Med Chem; 2000 Oct; 43(21):3852-61. PubMed ID: 11052790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased substrate affinity in the Escherichia coli L28R dihydrofolate reductase mutant causes trimethoprim resistance.
    Abdizadeh H; Tamer YT; Acar O; Toprak E; Atilgan AR; Atilgan C
    Phys Chem Chem Phys; 2017 May; 19(18):11416-11428. PubMed ID: 28422217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
    Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of selective inhibitors of dihydrofolate reductase: synthesis and antiparasitic activity of 2, 4-diaminopteridine analogues with a bridged diarylamine side chain.
    Rosowsky A; Cody V; Galitsky N; Fu H; Papoulis AT; Queener SF
    J Med Chem; 1999 Nov; 42(23):4853-60. PubMed ID: 10579848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
    Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
    Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction energy analyses of folate analog binding to human dihydrofolate reductase: contribution of the antifolate substructural regions to complex stability.
    Pitts C; Bowen D; Southerland WM
    Drug Metabol Drug Interact; 2000; 16(2):99-121. PubMed ID: 10962643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Receptor- and Ligand-based Models in Inverse Docking Experiments: Recognition of Dihydrofolate Reductase Using 7,8-Dialkyl- 1,3-Diaminopyrrolo[3,2-f]Quinazolines.
    Kumar SP; Jasrai YT; Pandya HA
    Curr Comput Aided Drug Des; 2016; 12(1):15-28. PubMed ID: 26725591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositioning of DHFR Inhibitors.
    Lele AC; Mishra DA; Kamil TK; Bhakta S; Degani MS
    Curr Top Med Chem; 2016; 16(19):2125-43. PubMed ID: 26881719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein flexibility and species specificity in structure-based drug discovery: dihydrofolate reductase as a test system.
    Bowman AL; Lerner MG; Carlson HA
    J Am Chem Soc; 2007 Mar; 129(12):3634-40. PubMed ID: 17335207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.
    Gokhale VM; Kulkarni VM
    J Comput Aided Mol Des; 2000 Jul; 14(5):495-506. PubMed ID: 10896321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
    Rutenber EE; Stroud RM
    Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding site.
    Pan R; Bowen D; Southerland WM
    Biopharm Drug Dispos; 1999 Oct; 20(7):335-40. PubMed ID: 10760841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor.
    Whitlow M; Howard AJ; Stewart D; Hardman KD; Chan JH; Baccanari DP; Tansik RL; Hong JS; Kuyper LF
    J Med Chem; 2001 Aug; 44(18):2928-32. PubMed ID: 11520201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic study of folate analogue binding to dihydrofolate reductases from different species.
    Sasso S; Gilli R; Lopez C; Sari JC; Briand C
    Adv Exp Med Biol; 1993; 338():521-4. PubMed ID: 8304171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.